Darrel W. Stafford, Carrboro US
Darrel W. Stafford, Carrboro, NC US
Patent application number | Description | Published |
---|---|---|
20100137211 | METHODS AND COMPOSITIONS FOR INTRA-ARTICULAR COAGULATION PROTEINS - The present invention provides methods and compositions for treating blood clotting factor disorders and/or reducing bleeding-associated joint damage by treatments delivered to the joint in a subject. | 06-03-2010 |
20100330059 | CHIMERIC FACTOR VII MOLECULES - The present invention relates to chimeric Factor VII polypeptides and methods of using the same. | 12-30-2010 |
20110154516 | HUMAN FACTOR IX VARIANTS WITH AN EXTENDED HALF LIFE - Factor IX variants are described with an increase in the number of glycosylation sites. The Factor IX variants have an increased half life and/or recovery. | 06-23-2011 |
20120064075 | CHIMERIC FACTOR VII MOLECULES WITH ENHANCED HALF LIFE AND METHODS OF USE - The present invention relates to novel proteins and methods of using chimeric Factor VIIa polypeptides. | 03-15-2012 |
20130337504 | Methods and Compositions for Producing Active Vitamin K-Dependent Proteins - The present invention provides methods and compositions for the production of vitamin K dependent proteins. | 12-19-2013 |
20140087458 | METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS - The present invention relates to methods and compositions for improving the productivity of recombinant vitamin K dependent protein expression in host cells. | 03-27-2014 |
20140302005 | CHIMERIC FACTOR VII MOLECULES - The present invention relates to chimeric Factor VII polypeptides and methods of using the same. | 10-09-2014 |
20150307863 | METHODS AND COMPOSITIONS FOR MODIFIED FACTOR IX PROTEINS - Factor IX proteins are described with an increase in the number of glycosylation sites and other modifications to provide Factor IX proteins that have higher specific activity and a longer useful clotting function relative to wild type or non-modified Factor IX protein. | 10-29-2015 |